A citation-based method for searching scientific literature

Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja, Richard Silver, Virginia Steen, Charlie Strange, Robert Wise, Fredrick Wigley, Maureen Mayes, David J Riley, Sabiha Hussain, Shervin Assassi, Vivien M Hsu, Bela Patel, Kristine Phillips, Fernando Martinez, Jeffrey Golden, M Kari Connolly, John Varga, Jane Dematte, Monique E Hinchcliff, Aryeh Fischer, Jeffrey Swigris, Richard Meehan, Arthur Theodore, Robert Simms, Suncica Volkov, Dean E Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A Molitor, Kristin Highland, Charles A Read, Marvin J Fritzler, Grace Hyun J Kim, Chi-Hong Tseng, Robert M Elashoff. Lancet Respir Med 2016
Times Cited: 373







List of co-cited articles
954 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
908
66

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
368
55

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
383
33

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
358
27

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Rachel K Hoyles, Ross W Ellis, Jessica Wellsbury, Belinda Lees, Pauline Newlands, Nicole S L Goh, Christopher Roberts, Sujal Desai, Ariane L Herrick, Neil J McHugh,[...]. Arthritis Rheum 2006
406
27

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
25

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
25

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
24

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
140
21

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
281
21

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna, Celia J F Lin, Daniel E Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler, Yoshihito Shima,[...]. Lancet Respir Med 2020
56
37

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Michael D Roth, Daniel E Furst, Richard M Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B Bolster,[...]. Am J Respir Crit Care Med 2007
262
20

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Nicole S Goh, Rachel K Hoyles, Christopher P Denton, David M Hansell, Elisabetta A Renzoni, Toby M Maher, Andrew G Nicholson, Athol U Wells. Arthritis Rheumatol 2017
121
20

Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj,[...]. Am J Respir Crit Care Med 2008
570
19

Systemic sclerosis.
Christopher P Denton, Dinesh Khanna. Lancet 2017
546
19

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E Furst, Philip J Clements, Dinesh Khanna,[...]. Ann Rheum Dis 2019
60
31

Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial.
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, Alakendu Ghosh, Parasar Ghosh. Rheumatology (Oxford) 2018
70
27

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler. Ann Rheum Dis 2015
217
19

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
Jacob M van Laar, Dominique Farge, Jacob K Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J Schuerwegh, Erik W A Marijt, Madelon C Vonk, Anton V Schattenberg,[...]. JAMA 2014
339
18

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, Peter A McSweeney, Ashley Pinckney, Beverly Welch, Maureen D Mayes, Richard A Nash, Leslie J Crofford, Barry Eggleston,[...]. N Engl J Med 2018
192
18

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Anthony J Tyndall, Bettina Bannert, Madelon Vonk, Paolo Airò, Franco Cozzi, Patricia E Carreira, Dominique Farge Bancel, Yannick Allanore, Ulf Müller-Ladner, Oliver Distler,[...]. Ann Rheum Dis 2010
606
18

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
18

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
Dinesh Khanna, Christopher P Denton, Celia J F Lin, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Ann Rheum Dis 2018
122
18

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
18

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
422
17

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
17

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.
Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R Seibold,[...]. J Rheumatol 2016
121
17

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
854
17

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.
E J Kim, B M Elicker, F Maldonado, W R Webb, J H Ryu, J H Van Uden, J S Lee, T E King, H R Collard. Eur Respir J 2010
278
16

Treatment Algorithms for Systemic Sclerosis According to Experts.
Andreu Fernández-Codina, Kyle M Walker, Janet E Pope. Arthritis Rheumatol 2018
74
20

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Richard K Burt, Sanjiv J Shah, Karin Dill, Thomas Grant, Mihai Gheorghiade, James Schroeder, Robert Craig, Ikuo Hirano, Karin Marshall, Eric Ruderman,[...]. Lancet 2011
272
15

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.
Dimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, Ioannis Antonopoulos, Theodora E Markatseli, Theodora Simopoulou, Panagiotis Georgiou, Andrew P Andonopoulos, Alexandros A Drosos, Lazaros Sakkas,[...]. Semin Arthritis Rheum 2017
90
16

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov,[...]. Ann Rheum Dis 2019
65
21

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Athol U Wells, Kevin R Flaherty, Kevin K Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A Wuyts, Susanne Stowasser,[...]. Lancet Respir Med 2020
95
14

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Pierre-Antoine Juge, Joyce S Lee, Esther Ebstein, Hiroshi Furukawa, Evgenia Dobrinskikh, Steven Gazal, Caroline Kannengiesser, Sébastien Ottaviani, Shomi Oka, Shigeto Tohma,[...]. N Engl J Med 2018
129
13

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
915
13

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.
Dimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, Christina Kalogeropoulou, Alexandra Kazantzi, Chaido Sirinian, Maria Karampetsou, Georgios Yiannopoulos, Andrew P Andonopoulos. Rheumatology (Oxford) 2010
240
13

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
Joshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, M Kristen Demoruelle, Evans R Fernandez-Perez, Aryeh Fischer, Stephen K Frankel, Stephen B Hobbs, Tristan J Huie, Jill Ketzer,[...]. Eur Respir J 2016
133
12

Mapping and predicting mortality from systemic sclerosis.
Muriel Elhai, Christophe Meune, Marouane Boubaya, Jérôme Avouac, Eric Hachulla, Alexandra Balbir-Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori,[...]. Ann Rheum Dis 2017
177
11

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
Anna-Maria Hoffmann-Vold, Håvard Fretheim, Anne-Kristine Halse, Marit Seip, Helle Bitter, Marianne Wallenius, Torhild Garen, Anne Salberg, Cathrine Brunborg, Øyvind Midtvedt,[...]. Am J Respir Crit Care Med 2019
48
22

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
11

Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Hayley Barnes, Anne E Holland, Glen P Westall, Nicole Sl Goh, Ian N Glaspole. Cochrane Database Syst Rev 2018
40
27

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Peter Saunders, Vicky Tsipouri, Gregory J Keir, Deborah Ashby, Marcus D Flather, Helen Parfrey, Daphne Babalis, Elisabetta A Renzoni, Christopher P Denton, Athol U Wells,[...]. Trials 2017
62
17


Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
361
11

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti,[...]. Lancet Respir Med 2020
46
23

Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Svetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, Daniel Rosenberg, Pia Moinzadeh, J Gerrard Coghlan, Athol U Wells, Christopher P Denton. Arthritis Rheumatol 2014
196
11


2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
871
10

Severe restrictive lung disease in systemic sclerosis.
V D Steen, C Conte, G R Owens, T A Medsger. Arthritis Rheum 1994
354
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.